Anderle, N.; Koch, A.; Gierke, B.; Keller, A.-L.; Staebler, A.; Hartkopf, A.; Brucker, S.Y.; Pawlak, M.; Schenke-Layland, K.; Schmees, C.
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer. Cancers 2022, 14, 2895.
https://doi.org/10.3390/cancers14122895
AMA Style
Anderle N, Koch A, Gierke B, Keller A-L, Staebler A, Hartkopf A, Brucker SY, Pawlak M, Schenke-Layland K, Schmees C.
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer. Cancers. 2022; 14(12):2895.
https://doi.org/10.3390/cancers14122895
Chicago/Turabian Style
Anderle, Nicole, André Koch, Berthold Gierke, Anna-Lena Keller, Annette Staebler, Andreas Hartkopf, Sara Y. Brucker, Michael Pawlak, Katja Schenke-Layland, and Christian Schmees.
2022. "A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer" Cancers 14, no. 12: 2895.
https://doi.org/10.3390/cancers14122895
APA Style
Anderle, N., Koch, A., Gierke, B., Keller, A. -L., Staebler, A., Hartkopf, A., Brucker, S. Y., Pawlak, M., Schenke-Layland, K., & Schmees, C.
(2022). A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer. Cancers, 14(12), 2895.
https://doi.org/10.3390/cancers14122895